Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PTi-guided versus hemodynamic-guided remifentanil dosing in laparoscopic abdominal surgery
ChiCTR2300078455Phase 4Not yet recruiting
- Sponsor
- The First Affiliated Hospital of Zhengzhou University
- Start
- Jun 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of remifentanil (2 arms), sponsored by The First Affiliated Hospital of Zhengzhou University. Primary endpoints: Remifentanil dosage, Average infusion rate of remifentanil and 1 more. Planned start Jun 2023; status: not yet recruiting.
02
Drugs
remifentanil
Beyond the preview
Go deeper on ChiCTR2300078455.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300078455.